BRIEF published on 07/09/2024 at 12:35, 1 year 8 months ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Multiple Sclerosis Immunic Vidofludimus Calcium COO Appointment Jason Tardio
BRIEF published on 07/09/2024 at 12:35, 1 year 8 months ago Immunic nomme Jason Tardio au poste de directeur de l'exploitation et président Sclérose En Plaques Vidofludimus Calcium Nomination Du COO Immunitaire Jason Tardio
PRESS RELEASE published on 07/09/2024 at 12:30, 1 year 8 months ago Immunic Appoints Jason Tardio as Chief Operating Officer and President Immunic appoints Jason Tardio as Chief Operating Officer and President, bringing extensive multiple sclerosis drug commercialization experience. Werner Gladdines promoted to Chief Development Officer Chief Operating Officer Multiple Sclerosis Immunic Jason Tardio Werner Gladdines
BRIEF published on 05/28/2024 at 12:35, 1 year 9 months ago Immunic to Participate in Industry and Scientific Conferences in June Biotechnology Investor Relations Conférences Chronic Diseases Scientific Engagement
BRIEF published on 05/28/2024 at 12:35, 1 year 9 months ago Immunic participera à des conférences industrielles et scientifiques en juin Biotechnologie Conférences Relations Avec Les Investisseurs Maladies Chroniques Engagement Scientifique
PRESS RELEASE published on 05/28/2024 at 12:30, 1 year 9 months ago Immunic to Participate in Industry and Scientific Conferences in June Immunic, Inc. (Nasdaq: IMUX) will participate in BIO International Convention 2024 and PCMG Assembly 2024 in June to present clinical pipeline of therapies for chronic inflammatory and autoimmune diseases Clinical Pipeline Immunic Inc IMUX BIO International Convention 2024 PCMG Assembly 2024
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Immunic, Inc. Announces Q1 2024 Financial Results and Corporate Updates Financial Strategy Immunic Inc Q1 2024 Financial Report Multiple Sclerosis Trials Celiac Disease Treatment
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 10 months ago Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update Immunic, Inc. reports first quarter 2024 financial results, including capital increase and progress in MS and gastrointestinal disease therapies Financial Results Clinical Trials Immunic Inc. Gastrointestinal Disease MS Therapy
BRIEF published on 05/06/2024 at 12:35, 1 year 10 months ago Immunic AG Announces Participation in May Conferences for Investor and Scientific Communities Investor Conferences Clinical Trials Immunic AG Scientific Conferences Autoimmune Disease Treatments
Published on 03/26/2026 at 08:05, 1 hour 54 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 5 hours 4 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 9 hours 19 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 9 hours 29 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 14 hours 44 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 09:44, 15 minutes ago FORTEC Elektronik Aktiengesellschaft publishes its half-year report – Acquisitions underpin revenue and earnings growth
Published on 03/26/2026 at 09:35, 24 minutes ago BORICA Reveals How Bulgaria Executed Euro Payments Cutover at National Scale in Partnership with OpenWay
Published on 03/26/2026 at 09:20, 39 minutes ago yoummday Wins a Texas Instruments 2025 Supplier Excellence Award
Published on 03/26/2026 at 09:05, 54 minutes ago Rockwell Automation Showcases Autonomous Industrial Operations at Hannover Messe 2026
Published on 03/26/2026 at 07:30, 2 hours 29 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 2 hours 29 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 15 hours 5 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
